Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kindred Group’s Q1 report 2024 and invitation to conference call

Kindred Group plc will publish its interim report for the first quarter 2024 on Wednesday 24 April 2024 at 07.30 (CEST).In connection with this, Kindred Group’s CEO Nils Andén and Interim CFO Patrick Kortman will host a web presentation in English at 10.00 (CEST) which is webcasted live on https://www.kindredgroup.com/Q12024. To access the telephone conference in connection with the presentation, please register at https://conference.financialhearings.com/teleconference/?id=5006359 

Gjensidige Forsikring ASA: Approval of prospectus

The Financial Supervisory Authority of Norway has on 8 April 2024 approved the prospectus prepared in connection with the application for listing on Oslo Børs for ISIN NO0013167189 FRN Gjensidige Forsikring ASA Subordinated Tier 2 Callable Bond Issue 2024/2054 and for ISIN NO0013177220 FRN Gjensidige Forsikring ASA 2024/Perpetual Restricted Tier 1 Non-Cumulative Callable Bond Issue. The approved supplement number 1 to the registration document and securities notes with summaries for ISIN NO0013167189 and for ISIN NO0013177220 are available on the company's web site: Investor Relations -

Etteplan's AI solution for information management brings savings to Kuopion Energia

ETTEPLAN OYJ, Press release, April 9, 2024 at 10.30 a.m. (EEST) Etteplan's AI solution for information management brings savings to Kuopion Energia Etteplan's Technical Communication Solutions’ AI-assisted service solution enhances work related to information management by identifying and extracting information from various drawings, enriching data in the document management system, and significantly reducing the time spent on information retrieval. The service solution will bring significant savings to Kuopion Energia in the future. "We are taking significant steps in harnessing

NOTICE OF THE ANNUAL GENERAL MEETING IN NEXAM CHEMICAL HOLDING AB (PUBL)

The shareholders of Nexam Chemical Holding AB (publ), 556919-9432 (“Nexam Chemical”), are hereby convened to the Annual General Meeting, to be held at 3.00 p.m. on Tuesday, May 14 2024 at Elite Hotel Ideon, Scheelevägen 27, in Lund.Right to participate and notification Shareholders wishing to attend the annual general meeting must · be listed in the share register kept by Euroclear Sweden AB on Friday, May 3 2024, and · not later than Tuesday, May 7 2024, inform Nexam Chemical in writing of their attendance and number of assistances, if any, to Nexam Chemical Holding AB (publ),

Biosergen resolves on a directed issue to underwriters in connection with the completed rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Biosergen AB (“Biosergen” or the “Company”) has, as previously announced on March 26, 2024, completed the rights issue of units, consisting of shares and warrants of series TO3 which was announced on January 30,

Intrance Medical Systems Inc signs LOI purchase commitment for clinical trials with Parkinson’s diseases patients

Tridentify are delighted to announce that Intrance Medical Systems Inc. now have signed a LOI purchase commitment of $ 300 000. Our Tridentify safeguarding solution will be used for the “logistic journey” of the drug component for clinical trials in at least Europe and the US for patients with Parkinson diseases in advanced stage. The clinical development program for US registration has recently been initiated, with a larger more extensive study planned for late 2024.- Intrance Medical Systems is focused on the development and commercialization of its lead clinical product for the treatment

BPC Instruments launches BPC[®] Air – an innovative and energy-efficient incubation solution for microbial cultivation

BPC Instruments AB (“BPC” or “the Company”) is announcing the global launch of its latest innovation, BPC[®] Air – an advanced air incubator offering both cooling and heating capabilities. Engineered to complement BPC’s respirometer systems, including BPC[®] Blue, AMPTS[®] III, and Gas Endeavour[®] III.  BPC[®] Air enriches the Company’s product line-up with state-of-the-art laboratory instruments tailored to diverse incubation temperature requirements for biogas production, biodegradability assessment, feed/food ingredients, and more. Paired with other respirometer systems provided by BPC,

Invitation to presentation of Q1 2024 interim report for Alleima

Alleima will publish its first quarter financial results on Tuesday April 23, 2024, at approximately 11:30 am CEST.A webcast and conference call for investors, analysts and financial media will be hosted at 1:00 pm CEST on April 23, 2024. Göran Björkman, President and CEO, as well as Olof Bengtsson, CFO, will present and comment on the report. To join the webcast online, access the presentation and other related materials, please visit Alleima’s website www.alleima.com/investors. Dial-in details for the conference call —    Sweden: +46 (0) 8 5051 0031 —    UK: +44 (0) 207 107

The future of livable cities starts with mobility

EasyPark Group is at the forefront of mobile paid parking, with a significant international presence. Over the last two decades, it has grown from a small Nordic startup to a global mobility platform provider. With a vision to make cities more livable, the Group has reshaped urban mobility and parking, earning it a place on the FT 1000 list of Europe’s fastest-growing companies in 2024. This achievement underscores its global success and expertise, which EasyPark Group will highlight at Intertraffic by showcasing how its mobility solutions contribute to smarter, sustainable urban environments.

Sustainability Report 2023: New steps towards carbon-neutral maritime transport and a strengthening of domestic capabilities

The introduction of biofuel, continuous development of the fleet and investments in Finnish providers were Viking Line’s most significant sustainability measures in 2023. In EPSI Rating’s 2023 customer satisfaction survey for maritime transport, for the second time Viking Line was named the most sustainable company in service between Finland and Sweden.In June 2023, Viking Line began offering passengers on the Turku route the option of purchasing renewable biofuel to offset their emissions. By choosing biofuel, passengers can reduce emissions from their journey by up to 90 per cent. “The

KONE to equip supertall 95-story Panda Tower in Chengdu, Western China

KONE Corporation, press release, April 9, 2024 KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply a suite of people flow solutions for the new 489-meter-high mixed-use Panda Tower (officially Chengdu Tianfu Supertall) in Chengdu, Western China. Towering to a height of 95 floors, the iconic structure will provide office, hotel, and retail space. Upon its projected completion in 2027, the Panda Tower is set to become Chengdu’s tallest. In terms of its structure, the high-rise development resembles a snow-capped mountain,

Notice of Annual General Meeting in Starbreeze AB (publ)

The shareholders of Starbreeze AB (publ), Reg. No. 556551-8932, are given notice of the Annual General Meeting to be held on Wednesday 15 May 2024 at 13.00 CEST in Styrelserummet, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden. Registration for the meeting starts at 12.30 CEST.The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Annual General Meeting also by postal voting.   Right to participate and notification Participation in the meeting room A) Anyone wishing to attend the meeting room in person or through a

Pär Åström has been appointed as the new CEO of Etac

The Board of Etac has appointed Pär Åström as CEO, effective from July 1 2024. Pär Åström is currently President of the Gardena Division in the Husqvarna Group. The appointment is a natural step as the current CEO Michael Wirzberger has previously informed the Board about his intention to retire.Etac is a world-leading developer of innovative assistive devices and patient handling equipment. Over the past 15 years Etac turnover has increased fivefold driven by M&A and strong organic growth. In 2023 Etac turnover amounted to 4 820 MSEK with over 90 % of sales outside Sweden and the majority

Invitation to presentation of Q1 2024 financial results

Viaplay Group will publish its Q1 2024 financial results at 07:30 CET on Tuesday 23 April. A conference call will be held at 09:00 CET on Tuesday 23 April with presentations from Jørgen Madsen Lindemann, President and CEO, and Enrique Patrickson, Chief Financial Officer. The call will be hosted by Matthew Hooper, Chief Corporate Affairs Officer, and a question-and-answer session will follow the presentations.   OnlineTo view slides and listen to the conference call online use the following link, where questions can also be posted: https://edge.media-server.com/mmc/p/qqgao8xx

TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc has increased its share capital by 255,200 A-shares (corresponding to a nominal value of USD 2,552.00) as a result of the exercise of a corresponding number of Restricted Share Units.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. All new shares are subscribed for in cash. 170,134 shares are subscribed for at DKK 0.07 per A-share and 85,066 shares are subscribed for at DKK 190.2 per A-share.   The new shares (i) are ordinary shares without any special rights and are negotiable instruments, (ii) give right to

Report of transactions in TORM plc securities by directors and executive officers and their closely associated persons

TORM plc has been notified of the following transaction in TORM plc securities:   +---------------------------------------+--------+-------------------------+|Details of the reporting person / closely associated person |+---------------------------------------+--------+-------------------------+|Name |Jacob Balslev Meldgaard |+---------------------------------------+--------+-------------------------+|Reason for the notification |+---------------------------------------+-

Invitation to Tobii Dynavox’s webcast following the interim report for the first quarter 2024

Tobii Dynavox will publish the interim report for the first quarter on April 23 at 7.30 a.m. CET. Following this report, at 9.00 a.m. CET, Tobii Dynavox will host a presentation for investors, analysts and media.    Tobii Dynavox’s President and CEO Fredrik Ruben and CFO Linda Tybring will present and comment on the report. The presentation will be held in English and can be viewed as a live webcast. After the main presentation, a Q&A session will follow where the participants are welcome to ask questions by using the online chat function. If you wish to ask questions verbally,

Tietoevry's first-quarter results on 25 April – invitation to a teleconference

Tietoevry Corporation          PRESS RELEASE          9 April 2024, 10.00 a.m. EEST   Tietoevry will publish its results for 1 January–31 March 2024 on Thursday 25 April 2024 at 9.00 a.m. EEST (8.00 a.m. CEST, 7.00 a.m. UK time).   A teleconference for analysts and media will be held at 10.00 a.m. EEST (9.00 a.m. CEST, 8.00 am UK time). Kimmo Alkio, President and CEO, and Tomi Hyryläinen, CFO, will present the results online in English. The presentation  can be followed on Tietoevry's website. 

Midsona's Annual and Sustainability Report 2023

Midsona’s Annual and Sustainability Report 2023 has been published and is available on the company’s website.The Annual and Sustainability Report is published and is available on Midsona’s website https://www.midsona.se/investerare/finansiell_information/arsrapport/. The printed version will be available end of April and will be distributed to shareholders who have ordered a copy. The Annual and Sustainability Report can be ordered by emailing info@midsona.com. The Annual and Sustainability Report is also available in European Single Electronic Format (ESEF) on the company’s website.

AegirBio’s chairman has announced his intention to leave the board of directors

Anders Ingvarsson, board member of AegirBio AB (“AegirBio” or the “Company”) since 2019, has announced his intention to resign as board member and chairman of AegirBio. The reason for the decision is personal reasons.Anders Ingvarsson will leave the board in connection with the extraordinary general meeting that the board intends to convene shortly, in accordance with the press release published earlier today. Notice of the extraordinary general meeting will be published in a separate press release. “I am pleased to note that the financing solution we have developed will facilitate the

BioStock: Prolight Diagnostics’ collaboration with G&H | ITL propels development

Prolight Diagnostics have appointed G&H | ITL for the development of its innovative point-of-care system, Psyros. The development project started in early 2023 and is steadily progressing. BioStock reached out to G&H’s CEO Charlie Peppiatt and Prolight Diagnostics’ Head of Engineering, Paul Monaghan, to gain further insight into the current status of development.Read the full article at biostock.se : https://www.biostock.se/en/2024/04/prolight-diagnostics-collaboration-with-gh-itl-propels-development/ This is a press release from BioStock - Connecting

AegirBio enters into a conditional agreement on a MSEK 45 loan facility with Atlas Special Opportunities and an agreement to amend the outstanding convertible bonds, subject to EGM approval

AegirBio AB (“AegirBio” or the “Company”) has today entered into a conditional agreement on a loan facility with Atlas Special Opportunities, LLC (“Atlas”) under which the Company can call for loans in seven (7) tranches (hereinafter “Tranches” or each “Tranche”) in an aggregate nominal amount of SEK 45.00 million before deduction of set-up fee (the “Loan Facility”) and transaction costs. The Loan Facility has been procured in order to secure continued financing of the Company’s operations, and to expedite the Company’s grant-awarding RADx® project under the auspices of the National

Acquisition

09 April 2024                                                                                                                Everest Global plc (“Everest” or the “Company”) Acquisition of 33% of Ace Jumbo Ventures Limited, a Hong Kong Type 9 and Type 4 Licence Holder The Company is pleased to announce that on 08 April 2024 it entered into a share purchase agreement (“SPA”) with Giga Treasure Limited (the “Seller”), to acquire 33 per cent. of the issued share capital of Ace Jumbo Ventures Limited (the “Target”) for US$20,000 in cash (the “Transaction”). The Target is the parent

Cereno Scientific announces extended patent protection in Europe for CS585 program

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that a patent has been approved (Notice of Allowance) in the first patent family for the preclinical Prostacyclin Receptor Agonist program, which includes drug candidate CS585. The patent expands the patent protection for the Prostacyclin Receptor Agonist program to also include Europe, one of the largest markets for cardiovascular disease.“I am pleased to announce the second patent in Europe for our preclinical Prostacyclin

There are no items matching the current filter
There are no more items matching the current filter
Back to top